{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-012333","form_type":"8-K","ticker":null,"cik":"0000859737","company_name":"HOLOGIC INC","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.491614+00:00","generated_at":"2026-05-23T21:56:56.418867+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Hologic appoints Wayde McMillan to Board of Directors","bullets":["Wayde McMillan, current CFO of Solventum, appointed to Hologic's Board effective April 4, 2025.","Also appointed to the Audit and Finance Committee.","Board size increased from eight to nine directors.","McMillan previously held CFO roles at Insulet and Medtronic's Minimally Invasive Therapies Group."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-012333","json":"https://secwatch.observer/filing/0001140361-25-012333.json","markdown":"https://secwatch.observer/filing/0001140361-25-012333.md","text":"https://secwatch.observer/filing/0001140361-25-012333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/ef20046823_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T21:56:56.418867+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11c49d1314","claim":"Wayde McMillan was appointed as Director at HOLOGIC INC.","evidence_excerpt":"increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ed37dcf35f","claim":"Wayde McMillan was appointed as director at HOLOGIC INC.","evidence_excerpt":"appointed Wayde McMillan as a director of the Company, effective April 4, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/859737/000114036125012333/0001140361-25-012333-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}